» Articles » PMID: 37524397

Don't Ignore Perimenopause

Overview
Journal CMAJ
Date 2023 Jul 31
PMID 37524397
Authors
Affiliations
Soon will be listed here.
References
1.
Prior J, Cameron A, Fung M, Hitchcock C, Janssen P, Lee T . Oral micronized progesterone for perimenopausal night sweats and hot flushes a Phase III Canada-wide randomized placebo-controlled 4 month trial. Sci Rep. 2023; 13(1):9082. PMC: 10241804. DOI: 10.1038/s41598-023-35826-w. View

2.
Santoro N, Crawford S, Lasley W, Luborsky J, Matthews K, McConnell D . Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab. 2008; 93(5):1711-21. PMC: 2386686. DOI: 10.1210/jc.2007-2165. View

3.
Prior J . Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev. 1998; 19(4):397-428. DOI: 10.1210/edrv.19.4.0341. View

4.
Lega I, Fine A, Antoniades M, Jacobson M . A pragmatic approach to the management of menopause. CMAJ. 2023; 195(19):E677-E672. PMC: 10185362. DOI: 10.1503/cmaj.221438. View

5.
Hitchcock C, Prior J . Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women. Menopause. 2012; 19(8):886-93. DOI: 10.1097/gme.0b013e318247f07a. View